Literature DB >> 15286248

Italian attention-deficit/hyperactivity disorder registry.

Pietro Panei, Romano Arcieri, Stefano Vella, Maurizio Bonati, Nello Martini, Alessandro Zuddas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15286248     DOI： 10.1542/peds.114.2.514

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  8 in total

1.  Attention-deficit/hyperactivity disorder drugs and growth: an Italian prospective observational study.

Authors:  Elena A P Germinario; Romano Arcieri; Maurizio Bonati; Alessandro Zuddas; Gabriele Masi; Stefano Vella; Flavia Chiarotti; Pietro Panei
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-09-11       Impact factor: 2.576

2.  More and better should be done to guarantee evidence-based management of ADHD in children across Europe.

Authors:  Laura Reale; Antonio Clavenna; Pietro Panei; Maurizio Bonati
Journal:  Eur J Pediatr       Date:  2013-10-24       Impact factor: 3.183

3.  Safety of Methylphenidate and Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): Data from the Italian National ADHD Registry.

Authors:  Samuele Cortese; Pietro Panei; Romano Arcieri; Elena A P Germinario; Annalisa Capuano; Lucia Margari; Flavia Chiarotti; Paolo Curatolo
Journal:  CNS Drugs       Date:  2015       Impact factor: 5.749

4.  Comorbidity prevalence and treatment outcome in children and adolescents with ADHD.

Authors:  Laura Reale; Beatrice Bartoli; Massimo Cartabia; Michele Zanetti; Maria Antonella Costantino; Maria Paola Canevini; Cristiano Termine; Maurizio Bonati
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-05-19       Impact factor: 4.785

5.  One-year prospective follow-up of pharmacological treatment in children with attention-deficit/hyperactivity disorder.

Authors:  Anna Didoni; Marco Sequi; Pietro Panei; Maurizio Bonati
Journal:  Eur J Clin Pharmacol       Date:  2011-05-03       Impact factor: 2.953

6.  Prescription drug dispensing profiles for one million children: a population-based analysis.

Authors:  Tingting Zhang; M Anne Smith; Pat G Camp; Salomah Shajari; Stuart M MacLeod; Bruce C Carleton
Journal:  Eur J Clin Pharmacol       Date:  2012-07-12       Impact factor: 2.953

7.  Acute Tolerability of Methylphenidate in Treatment-Naïve Children with ADHD: An Analysis of Naturalistically Collected Data from Clinical Practice.

Authors:  Gabriele Masi; Chiara Pfanner; Francesca Liboni; Francesca Lenzi; Arianna Villafranca; Giulia D'Acunto; Pamela Fantozzi; Francesca Falcone; Valerio Simonelli; Pietro Muratori; Valentina Levantini; Irene Favole; Federico Amianto; Chiara Davico; Benedetto Vitiello
Journal:  Paediatr Drugs       Date:  2022-02-09       Impact factor: 3.022

Review 8.  Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.

Authors:  Ole Jakob Storebø; Nadia Pedersen; Erica Ramstad; Maja Lærke Kielsholm; Signe Sofie Nielsen; Helle B Krogh; Carlos R Moreira-Maia; Frederik L Magnusson; Mathilde Holmskov; Trine Gerner; Maria Skoog; Susanne Rosendal; Camilla Groth; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Sasja J Håkonsen; Lise Aagaard; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2018-05-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.